Urosky Pharmaceuticals Private Limited

Urosky Pharmaceuticals Private Limited - chemicals in Pune, Maharashtra, India. Directors, charges & compliance details.
CIN U24100PN2022PTC208741 Incorporated 18 February 2022 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2025
₹8.61 Lakh
▲ 187% YoY
Net loss · FY 2025
₹15,383
Net margin -1.8%
EBITDA · FY 2025
-₹15,383
EBITDA margin -1.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Urosky Pharmaceuticals Private Limited

Data last updated:

Urosky Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 February 2022.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2022PTC208741.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Dattatrya Mahadev Maind and Ravindra Madhukar Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ph2 B Wing Flt No 40 G No 262/3 Adiraj Cluster Socap Bhugaon, Pune, Maharashtra, India – 412115.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15,383 (net margin -1.8%) and EBITDA of -₹15,383 (EBITDA margin -1.8%).

Urosky Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0458367).

Company details

CIN U24100PN2022PTC208741
Registration Number 208741
Incorporation Date 18 February 2022
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0458367
Key People
Dattatrya Mahadev Maind Director Ravindra Madhukar Jain Director

Recognitions & Rankings of Urosky Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-26-0458367

Contact details

Urosky Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.

  • Registered Address
    Ph2 B Wing Flt No 40 G No 262/3 Adiraj Cluster Socap Bhugaon, Pune, Maharashtra, India – 412115
  • Industry
    Chemicals, Manufacturing, Basic Chemical
Comprehensive company report
Urosky Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Urosky Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Urosky Pharmaceuticals Private Limited, buy the company report.

Financials of Urosky Pharmaceuticals Private Limited

FY 2025 filings available

Urosky Pharmaceuticals Private Limited reported revenue of ₹8.61 Lakh (up 187% YoY) for FY 2025.

Revenue · FY 2025
₹8.61 Lakh ▲ 187%
Net loss · FY 2025
₹15,383 margin -1.8%
EBITDA · FY 2025
-₹15,383 margin -1.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 187%
EBITDA CAGR growth
1 year
▲ 91%

Revenue rose 187% in the latest year. EBITDA rose 91% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15,383
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹15,383
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-1.8%
Net Profit Margin-1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Urosky Pharmaceuticals Private Limited, buy the company report.

Board of directors of Urosky Pharmaceuticals Private Limited

Urosky Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dattatrya Mahadev MaindDirector18 Feb 20224 Years 8 MonthsCurrent
Ravindra Madhukar JainDirector18 Feb 20224 Years 8 MonthsCurrent
View all directors

Peer comparison

Urosky Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vagakem Pharmaceuticals Private Limited₹8.64 Lakh (FY 2024)-8.0%Ghaziabad, Uttar Pradesh, India
Raajgeeta Pharmaceuticals Private Limited₹8.62 Lakh (FY 2025)-8.0%Pratapgarh, Uttar Pradesh, India
Urosky Pharmaceuticals Private Limitedthis company₹8.61 Lakh (FY 2025)-₹15,383-1.8%187.0%Pune, Maharashtra, India
JKC Pharmaceuticals Private Limited₹8.56 Lakh (FY 2025)1.0%Cuttack, Odisha, India
Acembic Pharmaceuticals Private Limited₹8.56 Lakh (FY 2022)38.0%Patna, Bihar, India

To see the full peer comparison of Urosky Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Urosky Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Urosky Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Urosky Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Dattatrya Mahadev Maind was appointed as Director on 18 Feb 2022.

AGM
Urosky Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Urosky Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Dattatrya Mahadev Maind was appointed as Director.
Appointed
Ravindra Madhukar Jain was appointed as Director.
Incorporation
18 Feb 2022
Urosky Pharmaceuticals Private Limited was registered on 18 Feb 2022 with Roc Pune & aged 4 years 8 months as per MCA records.

Frequently asked questions

Urosky Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 February 2022 (4+ years old) and is registered under CIN U24100PN2022PTC208741.

Urosky Pharmaceuticals has 2 current directors:

The latest financial statements of Urosky Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Urosky Pharmaceuticals is U24100PN2022PTC208741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Urosky Pharmaceuticals was incorporated on 18 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Urosky Pharmaceuticals by revenue are Vagakem Pharmaceuticals Private Limited, Raajgeeta Pharmaceuticals Private Limited, JKC Pharmaceuticals Private Limited, Acembic Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Dattatrya Mahadev Maind was appointed as Director on 18 Feb 2022. Ravindra Madhukar Jain was appointed as Director on 18 Feb 2022.

Yes, Urosky Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0458367).

The registered office of Urosky Pharmaceuticals is at Ph2 B Wing Flt No 40 G No 2623 Adiraj Cluster Socap Bhugaon, Pune, Maharashtra, India – 412115.

Urosky Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Urosky Pharmaceuticals can be reached at its registered office: Ph2 B Wing Flt No 40 G No 2623 Adiraj Cluster Socap Bhugaon, Pune, Maharashtra, India – 412115.